Sign Up For Live
Surfing The NASH Tsunami Podcast now includes Live Audience attendance during recordings. We record Monday afternoons EST, with invites sent out on Fridays. Our host Roger Green will invite you into the epsiode to ask your questions and to address your feedback regarding anything and everything in Fatty Liver Disease. Our usual Surfers will also be there too… each week… every episode!

43.1 – 2020 Year in Review: Advances in Fatty Liver Disease Drugs and Diagnostics

Vlad Ratziu discusses a "boiling hot" field of emerging NASH drugs and "particularly rich" data coming from no-invasive diagnostic testing

Despite elafibranor failing, obeticholic acid not securing FDA approval and COVID-19 related limitations in the conduct of clinical trials, “this was a very good year actually for NASH clinical trials,” with “some significant advances in terms of therapeutics for NASH” and . We had the results of several trials this year. We had the unfolding story of other molecules that are in development for NASH and all this makes for a very, very vibrant environment in terms of therapeutic research for NASH.” Further, MRI-based methods “are becoming mainstream,” starting to fulfill the promise of non-invasive testing.


More about Vlad Ratziu, MD, PhD

Request Transcript of This Episode
Request Transcript

Stay In Touch with Surfing NASH

Stay In Touch
  • Name
  • Email & NPI
  • Country
  • Institution & Profession